By February 2025 for semaglutide and March 2025 for tirzepatide, FDA declared both shortages resolved and transitional exemption windows ended
In the context of binge eating, weight loss and ADHD (if present), the medication does the heavy lifting of silencing the intrusive thoughts about food, but it doesnt teach us how to cope with a stressful workday, how to navigate binge urges when they arise, or how to regulate the overstimulated nervous system
Once you feel you can tolerate food and water again, you can resume your schedule
For deep dive on this zone specifically, see our jowls treatment guide, which addresses the same anatomical patterns from a non-GLP-1 angle
It has put its opinion forward to the European Commission for authorisation